Nichole Haeg: GLP-1s and Fertility
Nichole Haeg, Account Manager – Pharmacy Practice Specialist at American Health and Wellness, shared a post on LinkedIn:
“GLP-1s and Fertility – A secret key and a needed counseling point!
Here are my key take ways to consider:
- Currently, GLP-1s are not FDA approved for use in enhancing fertility, but research is ongoing.
- These medications show promise in improving fertility, especially in individuals with conditions like PCOS or obesity.
- The enhancement of fertility is attributed to factors such as weight reduction, improved insulin sensitivity, and the restoration of endocrine balance and endometrial receptivity.
- It is recommended to discontinue the use of GLP-1s four weeks before attempting conception and to avoid their use once pregnancy is confirmed.
- Ongoing research is crucial to gather more data on the effects of GLP-1s on fertility.
- For female patients not planning pregnancy, it’s important to educate them about the potential ‘side effect’ of increased fertility.
I am interested to see more research regarding this relationship between GLP-1s and fertility.
Tavares ACM, Martins MYM, de Souza GF, Lima EM, Rocha CA, de Souza LC, Simões JML, de Araújo NO, Cavalcante MB. Immunological effects of GLP-1 analogs on female reproduction: Therapeutic perspectives for infertility and recurrent pregnancy loss. J Reprod Immunol. 2025 Jun;169:104538. doi: 10.1016/j.jri.2025.104538. Epub 2025 May 8. PMID: 40359784.
Couldwell M, Tidwell AJ, Taylor AE. Impact of GLP1 agonists on reproduction. J Clin Endocrinol Metab. 2025 Jul 14:dgaf401. doi: 10.1210/clinem/dgaf401. Epub ahead of print. PMID: 40658801.
Sola-Leyva A, Pathare ADS, Apostolov A, Aleksejeva E, Kask K, Tammiste T, Ruiz-Durán S, Risal S, Acharya G, Salumets A. The hidden impact of GLP-1 receptor agonists on endometrial receptivity and implantation. Acta Obstet Gynecol Scand. 2025 Feb;104(2):258-266. doi: 10.1111/aogs.15010. Epub 2024 Dec 18. PMID: 39696822; PMCID: PMC11782050.”
-
Apr 15, 2026, 11:37Ally Murji: Honoured to be Part of the Canadian Session at the SEUD Meeting
-
Apr 15, 2026, 11:00Scammers are Targeting ESHRE2026 Attendees With Fake Registration and Hotel Offers – ESHRE
-
Apr 15, 2026, 10:24Join Us This Friday for Our “Research in Progress” – SRF
-
Apr 15, 2026, 10:20The Importance of Fertility Preservation in Turner Syndrome – RBMO
-
Apr 15, 2026, 10:16Marlena Fejzo: Our Study Identifying 6 New Genes Associated with Hyperemesis Gravidarum
-
Apr 15, 2026, 10:07Applications Are Open for the 2027 Cohort of the ASRM/SRBT CELL Program – ASRM
-
Apr 14, 2026, 15:14This Month’s F and S On Air Podcast Is Out Now – Fertility and Sterility
-
Apr 14, 2026, 14:51Lydia Akpan: Key Signs of Oocyte Dysmorphism
-
Apr 14, 2026, 14:42Emre Göksan Pabuçcu: Honored to Speak at the 12th National Gynecological Endoscopy Congress